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RESEARCH ARTICLE
Innate immune responses induced 
by the saponin adjuvant Matrix-M  
in specific pathogen free pigs
Viktor Ahlberg1, Bernt Hjertner1, Per Wallgren2, Stina Hellman1, Karin Lövgren Bengtsson3 
and Caroline Fossum1* 
Abstract 
Saponin-based adjuvants have been widely used to enhance humoral and cellular immune responses in many spe-
cies, but their mode of action is not fully understood. A characterization of the porcine transcriptional response to 
Matrix-M was performed in vitro using lymphocytes, monocytes or monocyte-derived dendritic cells (MoDCs) and 
in vivo. The effect of Matrix-M was also evaluated in specific pathogen free (SPF) pigs exposed to conventionally 
reared pigs. The pro-inflammatory cytokine genes IL1B and CXCL8 were up-regulated in monocytes and lymphocytes 
after Matrix-M exposure. Matrix-M also induced IL12B, IL17A and IFNG in lymphocytes and IFN-α gene expression in 
MoDCs. Several genes were indicated as up-regulated by Matrix-M in blood 18 h after injection, of which the genes 
for IFN-α and TLR2 could be statistically confirmed. Respiratory disease developed in all SPF pigs mixed with conven-
tional pigs within 1–3 days. Two out of four SPF pigs injected with saline prior to contact exposure displayed systemic 
symptoms that was not recorded for the four pigs administered Matrix-M. Granulocyte counts, serum amyloid A levels 
and transcription of IL18 and TLR2 coincided with disease progression in the pigs. These results support further evalu-
ation of Matrix-M as a possible enhancer of innate immune responses during critical moments in pig management.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Immunostimulatory effects of saponins from Quillaja 
saponaria Molina are known since nearly 100  years. 
These saponins have on numerous occasions been used in 
veterinary vaccines, but the mechanisms underlying the 
effects are not fully understood [1–4]. Purified fractions 
of Quillaja saponins combined with phospholipids and 
cholesterol can be formulated into nanoparticle ISCOM-
Matrix adjuvants [5, 6], such as the Matrix-M™ (Novavax 
AB, Uppsala, Sweden). Immunization experiments using 
Matrix-M as adjuvant reveal an antigen specific immune 
response characterized by long-lasting antibody produc-
tion, a balanced  TH1/TH2 cytokine profile and induc-
tion of cytotoxic T cells [7–9]. These adjuvant properties 
of Matrix-M also seem to increase the otherwise poor 
immunogenicity of Ebola virus glycoproteins [10].
In the pig, experimental vaccines formulated with 
ISCOM-Matrix have provided protection against pseu-
dorabies [11], rotavirus [12, 13], Toxoplasma gondii [14] 
and Mycoplasma hyopneumoniae [15]. Intramuscular 
injection of the adjuvant component Matrix-M alone 
in pigs resulted in cellular influx to the draining lymph 
node [16] as also seen for neutrophils, dendritic cells, 
monocytes and NK cells after subcutaneous injection of 
Matrix-M in mice [17, 18] and for monocytes in calves 
[19]. The innate immune reaction to intramuscular injec-
tion of Matrix-M in pigs was further characterized by a 
type I interferon-related transcriptional response both at 
the site of administration and in the draining lymph node 
[16, 20]. These indications that Matrix-M seems to acti-
vate the interferon system, amongst other innate immune 
parameters, raises the possibility for its strategic use in 
pigs that are extra vulnerable to infections.
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In modern pig husbandry disease susceptibility has 
been associated with weaning, transport and mixing, 
especially of pigs with different health status [21]. Physi-
ological stress and infectious agents co-operate and pre-
ventive treatments include administration of IFN-α [22, 
23] and β-glucans [24, 25]. Immunomodulators as a tool 
to boost the immune system against possible infections 
can potentially also be used in emergency vaccines [26]. 
In recent years it has been proposed that vaccine induced 
short-term innate immune responses possess a type of 
memory manifesting itself in a prolonged activation of 
innate immune cells which also acts on heterologous tar-
gets [27]. These non-specific effects of vaccines are now 
often referred to as “trained innate immunity” implying 
that priming of monocyte-derived cells and NK-cells by 
vaccination affects their future response to non-related 
agents [28].
The aim of the present study was to expand our under-
standing of how the saponin adjuvant Matrix-M may 
affect the response to different stressors such as infection 
and/or transport, building on previously acquired results 
on effects of Matrix-M administration to the pig [16, 20]. 
Therefore, we further evaluated modulatory effects of 
Matrix-M on innate immune parameters in the pig. To 
accomplish this, the host response to Matrix-M was eval-
uated in a 6-day contact exposure model using specific 
pathogen free (SPF) pigs treated with Matrix-M or saline 
1  day before transport and mixing with conventionally 
reared pigs. During this period leukocyte counts, serum 
amyloid A (SAA) and expression of immune related 
genes were monitored in blood. Furthermore, gene 
expression results from blood were complemented by 
those from in vitro exposure of porcine peripheral blood 
mononuclear cell (PBMC) subpopulations to Matrix-M.
Materials and methods
Animals
The SPF pigs (Yorkshire ×  Landrace) originated from a 
herd (Serogrisen, Ransta, Sweden) declared free from 
major swine pathogens. The conventionally reared pigs 
came from a farrow-to-finish herd with a high prevalence 
of respiratory lesions recorded at slaughter. Pigs in this 
herd were in general seronegative to Actinobacillus pleu-
ropneumoniae, Mycoplasma hyopneumoniae, Pasteur-
ella multocida and Streptococcus suis when transferred 
to fattening units at 11 weeks of age, but displayed high 
levels of serum antibodies to A. pleuropneumoniae and 
to P. multocida 8  weeks later. Porcine circovirus type 2 
(PCV2) was known to be present in both herds but there 
were no clinical signs of PCV2-associated diseases. All 
pigs were aged 9–11 weeks when included in the contact 
exposure experiment.
In vitro exposure to Matrix‑M
The transcriptional response to Matrix-M was studied 
in  vitro using PBMCs collected from SPF pigs (Lövsta 
Research Station, Uppsala, Sweden). The PBMCs were 
isolated from heparinized blood by centrifugation for 
45 min at 500g on FicollPaque PLUS (GE Healthcare Bio-
Sciences, Uppsala, Sweden), washed twice in PBS and 
resuspended in RPMI 1640 medium supplemented with 
20 mM HEPES buffer, 2 mM l-glutamine, 200 IU penicil-
lin/mL, 100  μg streptomycin/mL, 50  μM 2–mercaptoe-
thanol and 5% FCS (Gibco, Life Technologies, Carlsbad, 
CA, USA). Cell viability was determined with Trypan 
blue exclusion test and 10–20 × 106 PBMCs were seeded 
into 6-well plates (Nunclon, Nunc, Roskilde, Denmark) 
for further enrichment into subpopulations.
Monocytes were enriched from PBMCs by plastic 
adherence for 2/3  h. Thereafter the non-adherent lym-
phocyte-enriched cells (referred to as “lymphocytes”) 
were transferred to new 6-well plates. Monocyte-derived 
dendritic cells (MoDCs) were generated as previously 
described [29] by culturing monocytes for 5  days in the 
presence of rpIL-4 (40  ng/mL; R&D Systems, Minneapo-
lis, MN, USA) and rpGM-CSF (20 ng/mL; R&D Systems), 
replacing one-third of the culture volume after 3 days. The 
cells were used after 5 days when they had acquired a den-
dritic morphology. The resulting cell cultures were exposed 
to Matrix-M (1  μg/mL; Isconova AB, Uppsala, Sweden) 
that is delivered as a solution in PBS and easily blended into 
the culture medium. Lymphocytes were cultured for 3 days, 
with Matrix-M present for the last 6  h or 3  days. Mono-
cytes were cultured for 1  day, with Matrix-M present for 
the last 6 h. MoDCs were exposed to Matrix-M for 6 h after 
generation, or with Matrix-M present during the 5 days of 
generation. All cultures were grown in 2 mL of medium for 
indicated durations at 37 °C with 7%  CO2 in air.
Matrix‑M administration and contact exposure of SPF pigs
All pigs in the contact exposure experiment were cas-
trated males, aged 9–11 weeks. Two barrows from each 
of four SPF-litters received 150 μg Matrix-M (n = 8) sus-
pended in 1  mL sterile endotoxin-free 0.9% NaCl solu-
tion (saline; Fresenius Kabi, Uppsala, Sweden), and two 
other barrows in these litters received saline only (n = 8). 
The intramuscular injection was made into the thigh at 
equal distance from the knee and the ischial tuberosity. 
After 16  h, all SPF pigs were transported during 2  h to 
the National Veterinary Institute. At arrival (18  h), the 
SPF pigs were allotted to four experimental groups and 
allocated to three rooms. Four hours later (22 h), four of 
the eight conventionally reared pigs from four litters were 
mixed with four pigs treated with Matrix-M  (SPFMatrix-M/
Conv) and with four pigs treated with saline  (SPFSaline/Conv), 
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respectively, in different rooms according to a split-litter 
design. The remaining eight SPF pigs  (SPFMatrix-M/SPF and 
 SPFSaline/SPF) were housed in a third room. Thus, four 
experimental groups of four SPF pigs were established in 
three rooms with eight pigs in total per room (Figure 1). 
Each room of eight square metres, had individual venti-
lation and manure handling systems and an individual 
atrium for staff access. Pigs were fed 2% of their body-
weight with a commercial dry feed twice daily, and had 
free access to water and bedding material. The experi-
ment was approved by the Uppsala Ethical Committee on 
Animal Experiments (Reg. No. C 105214/15).
The health status of the animals was recorded daily 
and graded as 0  =  healthy; 1  =  moderately affected; 
2  =  clearly affected; 3  =  severely affected. Clinical 
signs of disease and respiratory signs were scored from 
0 (none) to 3 (severe) as described [30]. Blood was col-
lected by jugular venepuncture using vacuum tubes 
without additives or with EDTA (BD Vacutainer; BD 
Diagnostics, Franklin Lakes, NJ, USA), or PAXgene Blood 
RNA tubes (PreAnalytiX, Hombrechtikon, Switzerland), 
at time points indicated in Figure 1. Five days after mix-
ing, all pigs were sacrificed by electrical stunning and 
subsequent exsanguination. Macroscopic alterations of 
the draining lymph node, bronchial lymph node, lung 
and joints were scored from 0 (none) to 3 (severe).
RNA extraction
RNA from the in  vitro exposure experiment was 
extracted as described [31] using a combination of Trizol 
reagent (Invitrogen, Carlsbad, CA, USA) and RNA puri-
fication spin columns (E.Z.N.A. Total RNA Kit, Omega 
Biotek, Norcross, GA, USA). RNA from blood collected 
in PAXgene tubes during the in  vivo experiment was 
extracted using the PAXgene Blood RNA Kit (PreAna-
lytiX) and samples with low RNA yield were concen-
trated with the E.Z.N.A. MicroElute RNA Clean Up Kit 
(Omega Biotek). RNA concentration  (A260) and purity 
 (A260/280 and  A260/230) was determined by spectrophotom-
etry (NanoDrop 8000, NanoDrop Technologies, Mont-
chamin, DE, USA). Integrity of RNA was determined by 
capillary gel electrophoresis (Experion, BioRad, Hercules, 
CA, USA).
Synthesis of cDNA
Total RNA (250–1000 ng) from the in vitro and in vivo 
experiments were treated with RQ1 RNase-Free DNase 
(Promega, Madison, WI, USA) and DNA-free DNA 
Removal Kit (Life Technologies), respectively, followed 
by synthesis of cDNA with the GoScript Reverse Tran-
scription System (Promega). Each cDNA was diluted five 
times in nuclease free water and stored at −20  °C until 
analysis.
Figure 1 Experimental design. Sixteen SPF pigs were treated (0 h) with Matrix M (n = 8) or saline (n = 8) the evening before a 2-h transport 
to the animal facility. At arrival (18 h), the SPF pigs were allotted to three rooms. SPF pigs given Matrix-M or saline were mixed in the first room 
 (SPFMatrix-M/SPF and  SPFSaline/SPF; n = 4 + 4). Four hours later (22 h) eight conventionally reared pigs (Conv) arrived and were mixed with four of the 
SPF pigs given Matrix-M  (SPFMatrix-M/Conv) or four of those given saline  (SPFSaline/Conv; n = 4) in the other two rooms. Blood samples were collected 
from the SPF pigs in tubes without additives (serum), EDTA tubes and PAXgene Blood RNA tubes as indicated. Clinical examination was performed 
concurrently with blood sampling and at least once more each day. Post-mortem examination was performed on all pigs at termination of the 
experiment (6 days).
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Real‑time quantitative PCR (qPCR)
Transcripts specific for the genes CXCL8, IFITM3, 
IFNA, IFNB, IFNG, IL1B, IL6, IL10, IL12B, IL17A, SPP1, 
STING, TGFB1, TLR2, TLR4 and TNFA were quanti-
fied by qPCR using the QuantiTect SYBR Green PCR Kit 
(Qiagen) and an iQ5 Real Time PCR cycler (Bio-Rad). 
Each sample was amplified in duplicate 25  μL reactions 
with 2  μL cDNA (diluted  ×  5) and primers according 
to Table 1. The cycling conditions consisted of an initial 
cycle of 95 °C for 15 min followed by 40 cycles of 95 °C for 
15  s, the gene-specific annealing temperature (Table  1) 
for 30  s and 72  °C for 30  s. A melt-curve analysis was 
done at the end of the program for product verification.
To evaluate the level of genomic DNA contamination in 
the samples, the IFNA assay was used either on aliquots 
run in the cDNA synthesis without reverse transcriptase 
Table 1 Primer details and qPCR conditions
Conditions optimized or re-optimized for reagents and equipment described in “Materials and methods”.
a PCR efficiency estimated on serial dilutions of reference cDNA.
b Reference gene used for normalization.
Gene Primer sequence Anneal  
temp (°C)
Primer  
conc (nM)
Eff (%)a r2 Melt  
point (°C)
References
CXCL8 F: AGCCAGGAAGAGACTAGAAAGAAA
R: TTGGGGTGGAAAGGTGTG
56 500 97 0.998 81.5 New design
GAPDHb F: ACACTCACTCTTCTACCTTTG
R: CAAATTCATTGTCGTACCAG
56 500 94 0.998 80 [54]
HPRTb F: GGTCAAGCAGCATAATCCAAAG
R: CAAGGGCATAGCCTACCACAA
60 500 100 0.996 80 [55]
IFITM3 F: ATCAACATCCGAAGCGAGACC
R: GGAAAATTACCAGGGAGCCAGTG
56 500 96 0.999 85.5 New design
IFN-α F: AGCCTCCTGCACCAGTTCTG
R: TCACAGCCAGGATGGAGTCC
60 500 100 0.997 84.5 [20]
IFN-β F: TAGCACTGGCTGGAATGAAACC
R: TCAGGTGAAGAATGGTCATGTCT
58 400 104 0.993 79.5 [20]
IFN-γ F: TGGTAGCTCTGGGAAACTGAATG
R: GGCTTTGCGCTGGATCTG
60 400 102 0.998 76.5 [31]
IL1B F: GTGATGGCTAACTACGGTGACAA
R: CTCCCATTTCTCAGAGAACCAAG
60 400 91 0.999 79.5 [56]
IL6 F: CTGGCAGAAAACAACCTGAACC
R: TGATTCTCATCAAGCAGGTCTCC
60 400 98 0.994 77.5 [57]
IL10 F: CGGCGCTGTCATCAATTTCTG
R: CCCCTCTCTTGGAGCTTGCTA
60 400 100 0.995 80.5 [57]
IL12B F: TCTTGGGAGGGTCTGGTTTG
R: AAGCTGTTCACAAGCTCAAGTATGA
61 400 96 0.999 76.5 [31]
IL17A F: CAGACGGCCCTCAGATTACTCCA
R: AGCCCACTGTCACCATCACTTTCT
61 400 91 0.993 84.5 New design
PPIAb F: GCAGACAAAGTTCCAAAGACAG
R: AGATGCCAGGACCCGTATG
60 400 92 0.999 80.5 [58]
RPL32b F: CGGAAGTTTCTGGTACACAATGTAA
R: TGGAAGAGACGTTGTGAGCAA
55 300 97 0.997 77 [20]
SPP1 F: TTGGACAGCCAAGAGAAGGACAGT
R: GCTCATTGCTCCCATCATAGGTCTTG
56 300 93 0.997 82.5 [20]
STING F: TTACATCGGGTACCTGCGGC
R: CCGAGTACGTTCTTGTGGCG
56 500 101 0.992 82 [20]
TGFB1 F: TACGCCAAGGAGGTCACCC
R: CAGCTCTGCCCGAGAGAGC
60 400 90 0.992 83 [59]
TLR2 F: GGCAAGTGGATTATTGACAACATC
R: ACCACTCGCTCTTCACAAAGTTC
60 500 94 0.997 78.5 [60]
TLR4 F: CTTCACTACAGAGACTTCATTC
R: ACACCACGACAATAACCT
54 500 89 0.999 79 [61]
TNFA F: AGCCTCTTCTCCTTCCTCCTG
R: GAGACGATGATCTGAGTCCTTGG
60 400 91 0.993 84 [31]
YWHAZb F: ATTGGGTCTGGCCCTTAACT
R: GCGTGCTGTCTTTGTATGACTC
58 400 101 0.997 78.5 [20]
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(in vitro samples) or on the DNased total RNA at a con-
centration taking into account the dilution factor gener-
ated at cDNA synthesis (in vivo samples).
For initial analyses, cDNA from four pigs each in two 
experimental groups  (SPFMatrix-M and  SPFSaline) was 
pooled within each group and screened using a custom 
made (Additional file  1) dried-down qPCR plate array 
(PrimePCR, Bio-Rad). The expression of selected genes 
from the plate were further analysed in wet format (IL18, 
MYD88, NLRP3 and TLR9). All PrimePCR assays were 
run on the CFX96 Touch (Bio-Rad) using SsoAdvanced 
Universal  SYBR® Green Supermix (Bio-Rad) according 
to the manufacturer’s instructions. All reactions on the 
custom made plate were run as single reactions whereas 
assays in wet format were run in duplicates.
Reference genes and calculation of relative expression
Data acquired from the in vitro experiment was normal-
ized to the reference genes RPL32 and YWHAZ [20]. For 
the in vivo experiment, a total of five reference genes were 
evaluated (GAPDH, HPRT, PPIA, RPL32, YWHAZ), of 
which GAPDH, RPL32 and YWHAZ were present on the 
qPCR plate array. Based on geNorm analysis within the 
program qBasePLUS (Biogazelle), PPIA and RPL32 were 
selected for normalization of data (M = 0.345). Relative 
gene expression (fold change, FC) in samples was calcu-
lated to a calibrator, either untreated controls (in vitro) 
or the 0 h time point (in vivo), and normalized [32] to the 
aforementioned reference genes
DNA extraction and screening for PCV2
Blood samples from SPF pigs (0, 18  h or 5  days after 
mixing) and conventionally reared pigs (22  h or 5  days 
after mixing) were screened for presence of PCV2. DNA 
from 200 µL blood collected with EDTA as additive was 
extracted using the QIAamp DNA mini kit (Qiagen, 
Hilden, Germany), eluted in 100  µL elution buffer and 
the concentration and purity was determined by spectro-
photometry (Nanodrop 8000). The undiluted DNA was 
screened using a universal PCV2 assay (F: TAATTTTGC 
AGACCCGGAAAC; R: AGTAGATCATCCCACGGC 
AG) against the ORF1 reading frame [33] and the 
QuantiTect SYBR Green PCR Kit (Qiagen) as described 
above (56  °C annealing temperature; 96% efficiency). 
The presence of PCR inhibitors was evaluated by spiking 
selected negative samples with 2 ×  105 copies of PCV2 
DNA before analysis.
Blood and serum analyses
Total and differential white blood cell (WBC) counts 
were determined in blood collected with EDTA as 
additive using an automated cell counter (Exigo Vet-
erinary Hematology System; Boule Diagnostics, Spånga, 
Sweden). Blood samples without additives were centri-
fuged for 10  min at 800  g and serum was collected and 
stored at −20  °C until analysis. Serum amyloid A was 
determined using a commercial kit (Phase range Serum 
Amyloid A Assay; Tridelta Development, Maynooth, 
Ireland) according to the manufacturer’s instructions. 
Serum antibodies to M. hyopneumoniae and H. parasuis 
were analysed by commercial kits according to the manu-
facturers’ instructions (IDEXX M. hyo. Ab test, IDEXX, 
Westbrook, USA; Swinecheck HPS, Biovet, St Hyacinthe, 
Canada) and to A. pleuropneumoniae and P. multocida by 
indirect ELISA systems [30, 34].
Data and statistical analysis
Statistical analyses were performed in Excel (Micro-
soft) or Prism 5.0 (GraphPad Software). WBC counts 
are shown as mean ± SD and statistical differences ana-
lysed by Student’s t test. Gene expression is reported as 
fold change (FC) and shown as median or geometrical 
mean with SD. Statistical differences in gene expres-
sion between experimental groups or treatments were 
determined using the Mann–Whitney U test or, where 
applicable, the Wilcoxon matched-pairs signed rank 
test. Spearman correlation was calculated between gene 
expression and WBC counts. For all tests, p values less 
than 0.05 were regarded as significant and a gene with a 
FC < 0.5 or > 2 was considered as differentially expressed.
Results
Transcriptional response to Matrix‑M in vitro
The transcriptional response in lymphocytes, mono-
cytes and MoDCs was measured after short-term (6  h) 
and long-term (3 or 5  days) stimulation with Matrix-M 
(Table 2). During these conditions, gene expression of the 
pro-inflammatory cytokines IL-1β and CXCL8, but not 
TNF-α or IL-6, was up-regulated by Matrix-M in both 
lymphocytes and monocytes. Increased transcription of 
IL-6 was only detected in MoDCs that had been gener-
ated for 5 days in the presence of Matrix-M.
Expression of the  TH-related cytokine genes IL-12p40, 
IL-17A and IFN-γ was increased in lymphocytes cultured 
for 3 days in the presence of Matrix-M. These long-term 
exposed lymphocytes displayed a decreased transcription 
of IL-10. IFN-α transcription was up-regulated in MoDCs 
but not in any other cell type. IFN-β, the interferon-reg-
ulated gene IFITM3 and the type I interferon-associated 
genes STING and SPP1 remained unaffected by Matrix-
M. The expression of TLR2 was down-regulated in lym-
phocytes and in MoDCs exposed to Matrix-M.
In summary, in  vitro exposure to Matrix-M affected 
the gene expression for immunomodulatory cytokines, 
including IFN-α in cultures of porcine blood mono-
nuclear cells. These effects were most pronounced in 
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long-term cultures, but were also indicated in cultures 
exposed to Matrix-M for 6 h.
Transcriptional response to Matrix‑M in SPF pigs
The transcriptional response to Matrix-M was followed 
during 5 days in blood obtained from SPF pigs that were 
administered Matrix-M  (SPFMatrix-M/SPF; n = 4) or saline 
 (SPFSaline/SPF; n  =  4) and subjected to a 2-h transport. 
Pooled samples from pigs administered Matrix-M (n = 4) 
were compared to pooled samples from pigs given saline 
(n  =  4) using a qPCR plate array containing 92 genes 
representing innate immunity parameters. A transient 
increase in gene expression (FC > 2 compared to 0 h) was 
found for both groups after transport (Figure  2; Addi-
tional file 1). The increase appeared earlier in pigs admin-
istered Matrix-M (23 genes at 18 h, 19 genes at 30 h) than 
in those given saline (4 genes at 18 h, 24 genes at 30 h). 
Only a couple of genes were down-regulated (FC < 0.5) 
over this time period; CXCL10 and TLR7 in the Matrix-
M group and TNFA and FOXP3 in the saline group. 
Comparing FC values between groups at 18 h confirmed 
Table 2 Effects of Matrix-M on gene expression (relative gene expression versus untreated control) in cultures of porcine 
monocytes, lymphocytes and monocyte-derived dendritic cells (MoDC)
< >, gene not affected, i.e. 0.5 < FC < 2.
nd not detected; too few samples showed any expression of the gene of interest to allow FC calculation, – not analysed.
* p < 0.05 and ** p < 0.01 for difference in expression between Matrix-M treated samples and medium control (i.e. FC ≠ 1); Wilcoxon matched-pairs signed rank test.
a Total culture time.
b Matrix-M exposure time.
c Unless otherwise indicated.
d n = 4.
e n = 6.
Target name Lymphocytes 3 daysa Monocytes 1 daya MoDC 5 daysa
Matrix‑M 6 hb Matrix‑M 3 daysb Matrix‑M 6 hb Matrix‑M 6 hb Matrix‑M 5 daysb
n = 8c n = 8c n = 10c n = 6c n = 6c
IL-1β 2.0 9.6* 3.3* – –
IL-6 < > 3.9 2.1 < > 10.2*
TNF-α 2.5 < > < > – –
CXCL8 2.4* 5.9** 3.2** < > < >
IL-12p40 2.6* 2.6* nd – –
IL-17A 0.3 27.8* nd – –
IFN-γ < > 4.8* nd – –
IL-10 0.2* 0.4* < > – –
TGF-β < > < > – – –
IFN-α < > < > < > < > 3.8*
IFN-β nd nd nd < > 2.8
IFITM3 < >d < >d < > < >d < >d
SPP1 < >d < >d < >e < >d 0.2d
STING < >d < >d – < >d < >d
TLR2 0.4** 0.2 < > 0.3* 0.2*
0
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Figure 2 Gene regulation in pooled blood samples from pigs 
administered Matrix-M or saline. The number of up-regulated 
and down-regulated genes (fold change > 2 and < 0.5, respectively) 
in pooled blood from pigs administered Matrix-M (n = 4) or saline 
(n = 4), as analysed using a 92-gene qPCR plate array. The expression 
analysis is presented as the number of differentially expressed genes 
at each time point in relation to the 0 h time point (Matrix-M solid cir-
cles, saline open circles) or as the number of differentially expressed 
genes in Matrix-M pigs (up-regulated or down-regulated) in relation 
to the expression in saline pigs at each corresponding time point 
(depicted by the grey area).
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a higher expression (> twofold) of 19 genes in the Matrix-
M treated pigs (C3, CCR1, CD80, FOXP3, IFNGR1, IL18, 
IL1A, IRF7, JAK2, MYD88, NFKBIA, NLRP3, NOD1, 
NRAMP1, STAT3, TLR4, TLR8, TLR9 and TYK2).
Based on results from the pooled samples and the 
in  vitro data, IFN-α, IFN-β, CXCL8, IL1B, IL6, IL18, 
MYD88, NLRP3, TLR2, TLR4 and TLR9 were selected 
for analysis of gene expression in individual samples. 
The gene expression of MYD88 and NLRP3 displayed a 
similar kinetic as depicted by the qPCR plate array, i.e., 
an earlier increase in pigs administered Matrix-M com-
pared to those given saline (Figure 3A). In contrast, the 
expression of IL1B, TLR2 and TLR4 peaked at 18  h in 
both groups, whereas the expression of IL18 was highest 
at 30 h. Transcripts specific for CXCL8, IFN-β and IL-6 
were hardly detected and the average FC values for IFN-α 
and TLR9 did not exceed 2 in blood from the SPF pigs, 
regardless of treatment. However, statistical analysis of 
the gene expression data including samples from all SPF 
pigs at 18 h, i.e. before contact exposure, revealed a sig-
nificantly (p < 0.05) higher expression of IFN-α and TLR2 
in pigs administered Matrix-M than in those given saline 
(Figure  3B). At autopsy, the draining lymph node was 
enlarged in four of the eight pigs injected with Matrix-
M, indicating cell recruitment and/or cell proliferation 
(Table  3). No such reactions were recorded for any pig 
injected with saline.
Clinical effects of Matrix‑M in SPF pigs at contact exposure
To evaluate if the indicated immune activation by Matrix-
M had any clinical effect, SPF pigs where challenged by 
contact exposure to conventionally reared pigs 22 h after 
administration of Matrix-M  (SPFMatrix-M/Conv, Nos. 9–12) 
or saline  (SPFSaline/Conv, Nos. 13–16). The contact pigs 
were clinically healthy during the trial but lung lesions 
were recorded post-mortem in five of them (two out of 
four mixed with  SPFMatrix-M/Conv and three out of four 
mixed with  SPFSaline/Conv pigs). All conventionally reared 
pigs were seronegative to H. parasuis, whereas antibodies 
were detected in sera collected from eight SPF pigs origi-
nating from two litters. These antibody levels decreased 
significantly from day 0 to day 6 (p < 0.05; paired t test), 
indicating that they were of maternal origin. Both contact 
pigs and SPF pigs remained seronegative to M. hyopneu-
moniae, A. pleuropneumoniae and P. multocida through-
out the study. The experimental conditions did not affect 
the PCV2 viral load as no PCV2 DNA was detected in 
blood from any of the SPF or contact pigs before or at the 
end of the experiment.
No signs of respiratory disease or lesions in the respir-
atory tract were recorded for SPF pigs that were mixed 
with other SPF pigs  (SPFMatrix-M/SPF and  SPFSaline/SPF). 
None of the SPF pigs that were mixed with conventional 
pigs at 22  h showed any clinical signs of disease before 
the contact exposure. Thereafter all these SPF-pigs, 
irrespective of treatment, developed respiratory symp-
toms within 1–3  days that lasted throughout the study 
(Table 3). At necropsy, seven out of these eight SPF pigs 
displayed reactions in bronchial lymph nodes and/or 
lung. Lameness and decreased general condition were 
recorded in two out of the four SPF pigs administered 
saline (Nos. 14 and 16), with onset 2–4 days after mixing. 
These two pigs were the only ones displaying joint lesions 
at the post-mortem examination. In addition, ascetic 
fluid was found in the peritoneum of pig no. 14.
Thus, all challenged SPF pigs developed respiratory 
disease, but affected general health status and joint 
lesions were only recorded for pigs administered saline 
before the contact exposure. The draining lymph node 
was enlarged in four of the eight pigs receiving Matrix-
M (Nos. 3, 10, 11, 12) but not in any pig administered 
saline. One  SPFMatrix-M/SPF pig (No. 1) turned lame on day 
5, which was associated to a superficial abscess in the fet-
lock joint.
Granulocyte counts, SAA levels and gene expression 
in Matrix‑M treated SPF pigs during the contact exposure 
experiment
Granulocyte counts, SAA levels and gene expres-
sion were monitored for all SPF-pigs throughout the 
study. The granulocyte numbers increased after trans-
port (18  h) in all SPF groups, from 5.5 ±  1.4 ×  106 to 
10.6 ± 3.3 × 106/mL blood in pigs treated with Matrix-
M (n = 8) and from 5.6 ± 2.2 × 106 to 8.9 ± 3.3 × 106/
mL blood in pigs given saline (n =  8). The granulocyte 
numbers then returned to baseline and remained so in 
SPF pigs mixed with other SPF pigs (Figure  4A), except 
in the pig with an abscess in the fetlock joint (pig no. 
1), that had 10.5 × 106 granulocytes/mL blood at day 5. 
Increased levels of SAA were observed in all SPF groups 
at day 2, i.e. 1 day after allocation and mixing with other 
pigs. The SAA levels returned to baseline by day 4 in SPF 
pigs that were mixed with other SPF pigs (Figure 4B), but 
increased to 132 μg/mL in blood collected on day 6 from 
pig no. 1. This pig displayed increased gene expression 
of MyD88, IL18, NLRP3, TLR2 and TLR4 in blood col-
lected day 5. No such alteration in gene expression was 
recorded for any of the other SPF pigs mixed with SPF-
pigs, irrespective of treatment.
A second increase in granulocyte number was recorded 
following the contact exposure of SPF pigs to convention-
ally reared pigs (Figure 5). Among SPF pigs administered 
saline  (SPFSaline/Conv), the granulocyte counts remained 
elevated throughout the study and increased consider-
ably for pig nos. 14 and 16 at days 4 and 5. In these two 
pigs the SAA levels increased above 500  μg/mL from 
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Figure 3 Gene expression in blood of SPF pigs administered Matrix-M (solid line) or saline (open line). A Alterations of the gene expres-
sion over a 5 day period following administration of Matrix-M or saline (0 h), transport and mixing with non-littermates (18 h). FC values at indicated 
times are calculated against the 0 h time point and given as geometric mean ± SD, n = 4. B Gene expression for all SPF pigs, measured 18 h after 
injection of Matrix-M (n = 8) or saline (n = 8). FC values are calculated against the 0 h time point and individual FC values and geometric mean are 
given for each treatment.
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day 4 and onwards. An increased expression of IL18 and 
TLR2 was also obvious in blood samples collected from 
these pigs at the last occasions of sampling, i.e. when they 
displayed lameness and depressed general condition.
The granulocyte numbers in blood from pigs admin-
istered Matrix-M  (SPFMatrix-M/Conv) before the con-
tact exposure remained at baseline until day 5 when 
it increased in three of the four pigs (Nos. 10, 11, 12). 
This increase coincided with an increase in both SAA 
levels and expression of IL18 and TLR2 (Figure  5) and 
IL1B, TLR4 and MYD88 (data not shown) in blood from 
these pigs. Pig no. 11 had the highest granulocyte count 
and SAA level on the last day recorded. Furthermore, it 
also had a higher expression of IL18 than the other pigs 
already at 18 h, which also was evident for MYD88 and 
NLRP3 (data not shown). In contrast, pig no. 9 had a 
modest increase in granulocyte numbers and no increase 
in SAA levels on day 5 and 6, and generally showed the 
lowest variation in gene expression.
The expression of the IFN-α gene was not affected 
by contact exposure in either  SPFMatrix-M/Conv pigs or 
 SPFSaline/Conv pigs during the study (Figure  5). Similarly, 
IFN-β and IL-6 transcripts were only detected in a few of 
the SPF pigs, which were mixed with other SPF pigs (data 
not shown). The expression for IL1B, TLR4, MYD88 and 
NLRP3 generally increased in all pigs at 18 h but thereaf-
ter the individual variations were too large for conclusive 
results (data not shown).
Taken together, the expression pattern of several of 
the pro-inflammatory genes analysed correlated with 
changes in granulocyte counts and SAA levels. This 
relationship was further corroborated by a significant 
Table 3 Clinical score and post-mortem findings recorded for the SPF pigs in the natural challenge experiment
Pigs were administered Matrix-M (Nos. 1–4 and 9–12) or saline (Nos. 5–8 and 13–16) and were challenged by contact exposure (Nos. 9–16) or mixed with non-
littermate SPF pigs (Nos. 1–8).
DLN draining lymph node, BLN bronchial lymph node.
a Maximum score recorded.
b Days after mixing.
c Onset 4 days after mixing.
d Superficial abscess of 1 cm at fetlock joint.
e Onset 3 days after mixing.
f Ascetic fluid in the peritoneum.
Pig ID Clinical findings Post‑mortem examination
General condition Respiratory signs Other DLN Lung BLN Joints Other
Scorea Onsetb (day) Scorea Onsetb (day)
SPFMatrix-M/SPF
#1 – – – – Lamenessc – – – – Abscessd
#2 – – – – – – – – – –
#3 – – – – – 2 – – – –
#4 – – – – – – – – – –
SPFSaline/SPF
#5 – – – – – – – – – –
#6 – – – – – – – – – –
#7 – – – – – – – – – –
#8 – – – – – – – – – –
SPFMatrix-M/Conv
#9 – – 0.5 1 – – 0.5 1 – –
#10 – – 0.5 1 – 1 – 1 – –
#11 – – 0.5 2 – 1 0.5 – – –
#12 – – 1 3 – 1 0.5 – – –
SPFSaline/Conv
#13 – – 0.5 1 – – 0.5 0.5 – –
#14 2 3 1 1 Lamenesse – 3 1 3 Ascitesf
#15 – – 1 2 – – – 1 – –
#16 1 2 1 1 Lamenessc – – – 2 –
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correlation between granulocyte counts and the expres-
sion of TLR2 (p < 0.001; rho = 0.63; Spearman analysis 
for all pigs and time points).
Discussion
Immunomodulatory effects of Matrix-M were evaluated 
at contact exposure of SPF pigs to conventionally reared 
pigs. Although all contact SPF pigs in this model developed 
respiratory disease, only control pigs administered saline 
developed symptoms of systemic disease as evidenced 
by joint lesions. Granulocyte counts, levels of the acute-
phase protein SAA and gene expression of IL-18 and TLR2 
indicated a difference in kinetics of disease development 
between the two experimental groups. Pigs receiving intra-
muscular injection of Matrix-M, but not yet subjected to 
contact exposure, showed a statistically significant increase 
in expression of TLR2 and IFN-α in blood after 18 h.
Prior to the in vivo studies, in vitro effects of Matrix-
M on partially enriched porcine mononuclear cell 
populations were evaluated. Clearly upregulated genes 
included proinflammatory cytokines (IL-1β, CXCL8), 
 TH cytokines (IFN-γ, IL-12p40, IL-17A) and IFN-α. This 
up-regulation was most pronounced in PBMCs devoid of 
adherent cells, i.e., lymphocytes, when cultured for 3 days 
in the presence of Matrix-M. Lymphocytes cultured 
for only 16  h and exposed to Matrix-M for 6  h did not 
change their expression of any of the genes analysed (data 
not shown), in agreement with previous results [20]. The 
lymphocyte preparations in the current study were only 
partially purified, with no attempts to phenotypic char-
acterization of the cells. However, γδ T cells that can pro-
duce both IL-17 and IFN-γ reach high numbers in the 
porcine circulation [35, 36] that may have contributed to 
the relative increase in IL-17 and IFN-γ transcription in 
lymphocytes. IL-12 and IL-18 act synergistically on the 
IFN-γ production by porcine T cells [35] and IL-12p40 
transcripts were detected in lymphocytes cultured in the 
presence of Matrix-M. Thus, both the period of expo-
sure to Matrix-M and the total culture time as well as the 
cell composition appears important for the induction of 
cytokine gene expression by Matrix-M in vitro.
Most adjuvant effects are evaluated by in  vivo or 
in  vitro antigen re-stimulation. In such cases it is com-
paratively easy to profile the specific immunological 
response based on cytokine production, effector cell 
development and antibody isotypes. In the absence of 
antigen, adjuvant effects are solely monitored by innate 
immune parameters. However, innate immune reactions 
are influenced by mediators from several organs making 
them more problematic to assess in vitro. Using defined 
immunomodulators whole blood cultures have been used 
with some success to monitor cytokine profiles in man 
[37] and inflammatory biomarkers in pigs [38]. Still, the 
in  vitro system does not always reflect the in  vivo situ-
ation even in the case when defined immunomodulat-
ing molecules are used. PolyI:C and plasmid DNA both 
readily induced IFN-α in porcine tissue whereas these 
substances only induced low levels of IFN-α in porcine 
PBMC cultures, unless the inducers were pre-incubated 
with lipofectin [39, 40]. In accordance, previous in  vivo 
characterization of the immunomodulatory capacity 
of ISCOM-Matrix formulations, such as production of 
cytokines and activation of dendritic cells, has not been 
successfully reproduced in vitro [41].
The transcriptional response to Matrix-M was further 
evaluated in vivo. For that purpose SPF pigs were admin-
istered Matrix-M or saline 16  h before a 2-h transport 
and subsequent mixing with contact pigs. In line with 
earlier observations [42, 43], the transport and mix-
ing caused a transient increase in granulocyte counts 
0h 18
h
30
h 2d 3d 4d 5d 6d
0
5
10
15
10
6  g
ra
nu
lo
cy
te
s 
pe
r m
l
Time point
SPFMatrix-M/SPF
SPFSaline/SPF
0h 18
h
30
h 2d 3d 4d 5d 6d
0
100
200
300
400
Se
ru
m
 a
m
yl
oi
d 
A,
 µ
g/
m
l
Time point
SPFMatrix-M/SPF
SPFSaline/SPF
A
B
Figure 4 Granulocyte counts and SAA levels in blood of SPF 
pigs administered Matrix-M or saline. A Alterations in granulo-
cyte counts over a 5 day period following administration of Matrix-M 
or saline (0 h), transport and mixing with non-littermates at 18 h. 
Mean value ± SD, n = 4. B Alterations in SAA over a 5 day period 
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Figure 5 Granulocyte counts, SAA and gene expression in blood of SPF pigs administered Matrix-M or saline. The pigs were admin-
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(at 18  h) and SAA levels (at day 2) with no differences 
between pigs administered Matrix-M and those given 
saline. These effects were therefore attributed to the 
“stress” all pigs experienced. An increased transcription 
appeared for approximately 20% of the 92 innate immu-
nity genes assessed in the pooled blood samples. This 
increase was evident in pooled samples collected both at 
18 and 30 h from  SPFMatrix-M pigs but only found at 30 h 
in pooled samples from  SPFSaline pigs. Of these genes 
only two (NFKBIA and S100A8) were identified as dif-
ferentially expressed in a whole transcriptomic analysis 
of blood cells from pigs after ACTH administration [44]. 
However, SAA, IL-6, IgA and IL-18 are all suggested as 
biomarkers of “stress” in the pig [45]. Furthermore, stud-
ies in man indicate an intrinsic network between gluco-
corticosteroids, SAA, cytokines, chemokines, TLR2 and 
TLR4 [46]. Thus, it is likely that the physiological effect 
of transport masked effects on the transcription of innate 
immune genes caused by Matrix-M administration.
When individual samples at time point 18 h were ana-
lysed, only the expression of IFN-α and TLR2 was signifi-
cantly increased in pigs administered Matrix-M compared 
to saline. This increased gene expression of IFN-α is in line 
with the induction of interferon-regulated genes in mus-
cle and draining lymph node from pigs 24 h after admin-
istration of Matrix-M [16]. Subsequent analyses also 
demonstrated IFN-β transcripts as well as a low expression 
of SPP1 and STING in some of these lymph nodes [20]. 
When analysed in vitro, IFNB, STING and SPP1 showed 
no expression or were down-regulated whereas IFN-α was 
up-regulated in long-term cultures of MoDC. Similarly, the 
expression of TLR2 was down-regulated when analysed 
in  vitro but significantly up-regulated in blood from the 
SPF-pigs administered Matrix-M. TLR2 was also highly 
up-regulated locally after intramuscular injection with 
Matrix-M in pigs [16] and analysis on archived material 
from that study revealed a tendency toward up-regulation 
of TLR2 in PBMCs isolated 17 h after the injection (data 
not shown). In blood, porcine TLR2 is mostly expressed 
on monocytes, with some expression on granulocytes and 
no expression on lymphocytes [47]. Thus, changes in the 
blood relative cellular composition for example caused by 
altered mononuclear cell migration and polymorphonu-
clear cell influxes need to be considered amongst other 
factors when evaluating gene expression in blood sam-
ples [48]. Differences between adjuvant effects recorded 
in vitro and in vivo may hinder the evaluation of mecha-
nistic effects [49] and co-culture systems with endothelial 
cells can better reflect the in  vivo situation when using 
PBMC for evaluation of immune activators [50].
Based on the results from in  vitro data and previous 
reports on the immunostimulatory effect of Matrix-M [16] 
we hypothesized that Matrix-M could act prophylactic or 
therapeutic to affect the clinical outcome of a natural infec-
tion. Experience from porcine reproductive and respira-
tory syndrome virus [22] and PCV2 [51] demonstrate that 
infectious diseases in production animals are often multi-
factorial and may benefit from stressors such as weaning, 
transport and mixing of groups [21]. In an effort to imitate 
field conditions, SPF pigs were subjected to non-infectious 
stress from transport and mixing of groups and to infec-
tious stress by contact exposure to conventionally reared 
pigs (Figure 1). Two of the SPF pigs that were administered 
saline before contact exposure developed signs of systemic 
disease that resembled Glässer’s disease [52]. This syn-
drome is caused by H. parasuis infection and is commonly 
associated with transport and mixing of pigs of different 
health status. Post-mortem examination supported this 
diagnosis, but H. parasuis could not be recovered from 
affected organs by cultivation. However, the presence of H. 
parasuis was demonstrated by metagenomic sequencing 
of 16S rRNA genes (SciLifeLab, Uppsala, Sweden, data not 
shown) and the low level of serum antibodies to H. paras-
uis indicated that the pigs were at risk to develop disease. 
The affected pigs expressed high levels of SAA and granu-
locyte counts following the onset of clinical symptoms. 
Notably, the SAA levels correlated with severity of disease, 
as outlined in [53], as well as to the expression of IL18 and 
TLR2. The SAA levels and granulocyte counts returned to 
baseline after the initial peak in all other SPF pigs mixed 
with conventional pigs, irrespective of treatment. Thus, 
there appeared no systemic inflammation in these pigs, 
although all SPF pigs developed respiratory symptoms. 
However, in three out of four challenged SPF pigs receiv-
ing Matrix-M, both SAA levels, granulocytes counts and 
transcription of IL1B, IL18, MYD88, NLRP3, TLR2 and 
TLR4 increased on the last day recorded. All these param-
eters were also increased in the control pig (No. 1) suf-
fering from an abscess, further supporting their use as 
indicators of inflammation. This suggests that Matrix-M 
did not fully protect against systemic disease, but affected 
the disease kinetics as innate immune responses appeared 
later after challenge in Matrix-M injected pigs (Figure 5).
Taken together, both the in  vitro and in  vivo results 
indicate an immunomodulatory effect of Matrix-M in the 
pig. In the contact exposure model, Matrix-M seemed 
to be able to reduce or delay systemic symptoms resem-
bling Glässer’s disease. There was no discernible effect on 
local respiratory symptoms but this might be overcome 
by employing a different route of administration. If these 
indications can be confirmed in the field, Matrix-M could 
be suitable to enhance innate immune responses during 
critical moments in pig management. Equally impor-
tant, the capacity to a rapid activation of innate immune 
parameters is highly desirable in adjuvants used for 
emergency vaccination.
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